HighPoint Advisor Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-760
Closed -$427K 885
2025
Q4
$427K Sell
760
-50
-6% -$28.4K 0.01% 714
2025
Q3
$416K Buy
810
+22
+3% +$9.61K 0.02% 438
2025
Q2
$247K Sell
788
-2
-0.3% -$600 0.01% 583
2025
Q1
$242K Sell
790
-5
-0.6% -$1.68K 0.01% 556
2024
Q4
$261K Buy
795
+158
+25% +$53.6K 0.01% 559
2024
Q3
$204K Buy
+637
New +$242K 0.01% 617

Other funds holding MEDP

HighPoint Advisor Group's MEDP Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Medpace (MEDP) in Q1 2026, closing a stake of 760 shares — an estimated $427K sold.

HighPoint Advisor Group first reported a position in MEDP in Q3 2024 and held it in 6 quarters. The position peaked at $427K in Q4 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • HighPoint Advisor Group reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 760 Medpace shares in Q1 2026, an estimated $427K.
  • HighPoint Advisor Group first reported a position in Medpace in Q3 2024 and held it in 6 quarters.
  • HighPoint Advisor Group's Medpace position peaked at $427K in Q4 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.